Corneal cross-linking for treatment of progressive keratoconus in various age groups

Journal of Refractive Surgery

Volumn 30, Issue 7, 2014, Pages 454-460

  Soeters, Nienke ^a   Van Der Valk, Rikkert ^a   Tahzib, Nayyirih G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Zonnestraal Eye Hospital Amersfoort   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUOROMETHOLONE; RIBOFLAVIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CORNEA; CORNEA SURGERY; CORNEAL CROSSLINKING; CORNEAL CROSSLINKING DEVICE; ENDOTHELIUM CELL; FOLLOW UP; GROUPS BY AGE; HUMAN; INTRAOCULAR PRESSURE; KERATOCONUS; KERATOMETRY; MAJOR CLINICAL STUDY; MEDICAL DEVICE; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION; VISUAL ACUITY;

ADOLESCENT; ADULT; AGING; CELL COUNT; CHILD; COLLAGEN; CORNEAL PACHYMETRY; CORNEAL STROMA; CORNEAL TOPOGRAPHY; CROSS-LINKING REAGENTS; DISEASE PROGRESSION; ENDOTHELIUM, CORNEAL; FEMALE; HUMANS; KERATOCONUS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; REFRACTION, OCULAR; RIBOFLAVIN; ULTRAVIOLET RAYS; VISUAL ACUITY; YOUNG ADULT;

EID: 84904399075     PISSN: 1081597X     EISSN: 19382391     Source Type: Journal    
DOI: 10.3928/1081597X-20140527-03     Document Type: Article

References (29)

1. Ertan A, Muftuoglu O. Keratoconus clinical findings according to different age and gender groups. Cornea. 2008;27:1109-1113.
2. Reeves SW, Stinnett S, Adelman RA, Afshari NA. Risk factors for progression to penetrating keratoplasty in patients with keratoconus. Am J Ophthalmol. 2005;140:607-611.
3. Tuft SJ, Moodaley LC, Gregory WM, Davison CR, Buckley RJ. Prognostic factors for the progression of keratoconus. Ophthalmology. 1994;101:439-447. (Pubitemid 24100567)
4. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998;66:97-103. (Pubitemid 28070342)
5. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627. (Pubitemid 36457967)
6. Randleman JB. Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus. Am J Ophthalmol. 2013;155:612-613.
7. Soeters N, Van der Lelij A, van der Valk R, Tahzib NG. Corneal crosslinking for progressive keratoconus in four children. J Pediatr Ophthalmol Strabismus. 2011;48:e26-e29.
8. Caporossi A, Mazzotta C, Baiocchi S, Caporossi T, Denaro R. Age-related long-term functional results after riboflavin UVA corneal cross-linking. J Ophthalmol. 2011;2011:608041.
9. Zotta PG, Moschou KA, Diakonis VF, et al. Corneal collagen cross-linking for progressive keratoconus in pediatric patients: a feasibility study. J Refract Surg. 2012;28:793-799.
10. Chatzis N, Hafezi F. Progression of keratoconus and efficacy of pediatric corneal collagen cross-linking in children and adolescents. J Refract Surg. 2012;28:753-758.
11. Vinciguerra P, Albé E, Frueh BE, Trazza S, Epstein D. Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus. Am J Ophthalmol. 2012;154:520-526.
12. Caporossi A, Mazzotta C, Baiocchi S, Caporossi T, Denaro R, Balestrazzi A. Riboflavin-UVA-induced corneal collagen crosslinking in pediatric patients. Cornea. 2012;31:227-231.
13. Arora R, Gupta D, Goyal JL, Jain P. Results of corneal collagen cross-linking in pediatric patients. J Refract Surg. 2012;28:759-762.
14. Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35:1358-1362.
15. Vinciguerra R, Romano MR, Camesasca FI, et al. Corneal cross-inking as a treatment for keratoconus: four-year morphologic and clinical outcomes with respect to patient age. Ophthalmology. 2013;120:908-916.
16. Koller T, Pajic B, Vinciguerra P, Seiler T. Flattening of the cornea after collagen crosslinking for keratoconus. J Cataract Refract Surg. 2011;37:1488-1492.
17. Roy AS, Dupps WJ. Patient-specific computational modeling of keratoconus progression and differential responses to collagen cross-linking. Invest Ophthalmol Vis Sci. 2011;52:9174-9187.
18. Koller T, Schumacher S, Fankhauser F II, Seiler T. Riboflavin/ultraviolet a crosslinking of the paracentral cornea. Cornea. 2013;32:165-168.
19. Greenstein SA, Fry KL, Hersh PS. Effect of topographic cone location on outcomes of corneal collagen cross-linking for keratoconus and corneal ectasia. J Refract Surg. 2012;28:397-405.
20. Sloot F, Soeters N, van der Valk R, Tahzib NG. Effective corneal collagen crosslinking in advanced cases of progressive keratoconus. J Cataract Refract Surg. 2013;39:1141-1145.
21. Krumeich JH, Daniel J, Knülle A. Live-epikeratophakia for keratoconus. J Cataract Refract Surg. 1998;24:456-463. (Pubitemid 30195921)
22. Léoni-Mesplié S, Mortemousque B, Touboul D, et al. Scalability and severity of keratoconus in children. Am J Ophthalmol. 2012;23:1-8.
23. Wang M. Keratoconus vs pellucid marginal degeneration. In: Wang M, ed. Keratoconus and Keratoectasia: Prevention, Diagnosis, and Treatment. Thorofare, NJ: SLACK Incorporated; 2010:39.
24. Lee BW, Jurkunas UV, Harissi-Dagher M, et al. Ectatic disorders associated with a claw-shaped pattern on corneal topography. Am J Ophthalmol. 2007;144:154-156.
25. Tu KL, Aslanides IM. Orbscan II anterior elevation changes following corneal collagen cross-linking treatment for keratoconus. J Refract Surg. 2009;25:715-722.
26. Wisse RP, Godefrooij DA, Soeters N, Imhof SM, Van der Lelij A. A multivariate analysis and statistical model for predicting visual acuity and keratometry one year after crosslinking for keratoconus. Am J Ophthalmol. 2014;157:519-525.
27. Greenstein SA, Shah VP, Fry KL, Hersh PS. Corneal thickness changes after corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg. 2011;37:691-700.
28. Caporossi A, Mazzotta C, Baiocchi S, Caporossi T. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol. 2010;149:585-593.
29. O'Brart DPS, Kwong TQ, Patel P, McDonald RJ, O'Brart NA. Long-term follow-up of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linking to halt the progression of keratoconus. Br J Ophthalmol. 2013;97:433-437.